These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 105053)

  • 1. Antibody responses of human infants to three doses of group A Neisseria meningitidis polysaccharide vaccine administered at two, four, and six months of age.
    Gold R; Lepow ML; Goldschneider I; Draper TF; Gotschlich EC
    J Infect Dis; 1978 Dec; 138(6):731-5. PubMed ID: 105053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants.
    Rennels MB; Edwards KM; Keyserling HL; Reisinger K; Blatter MM; Quataert SA; Madore DV; Chang I; Malinoski FJ; Hackell JG; Paradiso PR
    Pediatr Infect Dis J; 2001 Feb; 20(2):153-9. PubMed ID: 11224833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children.
    Gold R; Lepow ML; Goldschneider I; Draper TF; Gotshlich EC
    J Infect Dis; 1979 Nov; 140(5):690-7. PubMed ID: 118997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines.
    Lepow ML; Goldschneider I; Gold R; Randolph M; Gotschlich EC
    Pediatrics; 1977 Nov; 60(5):673-80. PubMed ID: 411104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants.
    Campbell H; Byass P; Ahonkhai VI; Vella PP; Greenwood BM
    Pediatrics; 1990 Jul; 86(1):102-7. PubMed ID: 2113671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterization of responses of infants and children to meningococcal A polysaccharide vaccine.
    Wilkins J; Wehrle PF
    J Pediatr; 1979 May; 94(5):828-32. PubMed ID: 109592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children.
    Käyhty H; Karanko V; Peltola H; Sarna S; Mäkelä PH
    J Infect Dis; 1980 Dec; 142(6):861-8. PubMed ID: 6780634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.
    Leach A; Twumasi PA; Kumah S; Banya WS; Jaffar S; Forrest BD; Granoff DM; LiButti DE; Carlone GM; Pais LB; Broome CV; Greenwood BM
    J Infect Dis; 1997 Jan; 175(1):200-4. PubMed ID: 8985221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of O-acetyl-negative and -positive polysaccharide vaccines for infections with Neisseria meningitidis group C in infants.
    Pichichero M; Anderson P; Gotschlich E; Kamm J; McMullen A; Nielsen S
    J Infect Dis; 1985 Oct; 152(4):850-1. PubMed ID: 3930623
    [No Abstract]   [Full Text] [Related]  

  • 10. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.
    Twumasi PA; Kumah S; Leach A; O'Dempsey TJ; Ceesay SJ; Todd J; Broome CV; Carlone GM; Pais LB; Holder PK
    J Infect Dis; 1995 Mar; 171(3):632-8. PubMed ID: 7876610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of serum anticapsular antibody after a two-dose regimen of a Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine and anamnestic response after a third dose.
    Sood SK; Ballanco GA; Daum RS
    J Pediatr; 1991 Oct; 119(4):652-4. PubMed ID: 1919901
    [No Abstract]   [Full Text] [Related]  

  • 12. Who should be given meningococcal vaccine?
    Lancet; 1978 Dec; 2(8101):1185-6. PubMed ID: 82146
    [No Abstract]   [Full Text] [Related]  

  • 13. Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976).
    Parke JC; Schneerson R; Robbins JB; Schlesselman JJ
    J Infect Dis; 1977 Aug; 136 Suppl():S51-6. PubMed ID: 408433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
    Cui XL; Wu X; Li MQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis.
    Gold R; Lepow ML; Goldschneider I; Gotschlich EC
    J Infect Dis; 1977 Aug; 136 Suppl():S31-5. PubMed ID: 408431
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological effectiveness of a dried group-A meningococcal polysaccharide vaccine].
    Alliluev AP; Kotel'nikova OV; Chernyshova TF; Skirda TA; Kuvakina VI
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Mar; (3):106-12. PubMed ID: 6428089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization.
    Ceesay SJ; Allen SJ; Menon A; Todd JE; Cham K; Carlone GM; Turner SH; Gheesling LL; DeWitt W; Plikaytis BD
    J Infect Dis; 1993 May; 167(5):1212-6. PubMed ID: 8486957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of growth-inhibiting (bactericidal) antibodies in patients with meningococcal meningitis and in subjects immunized with meningococcal polysaccharide vaccine by a [3H]thymidine assay.
    Hassan-King M; Greenwood BM; Whittle HC
    J Clin Microbiol; 1985 Jul; 22(1):136-8. PubMed ID: 3926814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.